BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28285170)

  • 21. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological profile of patients with systemic sclerosis.
    Wielosz E; Dryglewska M; Majdan M
    Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques.
    Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F
    Clin Exp Rheumatol; 2012; 30(5):748-55. PubMed ID: 22765957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe oesophageal disease and its associations with systemic sclerosis.
    Karamanolis GP; Denaxas K; Panopoulos S; Bournia KV; Zorbala A; Kamberoglou D; Schizas D; Ladas SD; Sfikakis PP
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):82-85. PubMed ID: 28869413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
    Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
    Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
    Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
    J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
    Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP;
    Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.
    Colaci M; Giuggioli D; Vacchi C; Lumetti F; Iachetta F; Marcheselli L; Federico M; Ferri C
    Autoimmun Rev; 2014 Feb; 13(2):132-7. PubMed ID: 24103404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.
    Valenzuela A; Baron M; ; Herrick AL; Proudman S; Stevens W; ; Rodriguez-Reyna TS; Vacca A; Medsger TA; Hinchcliff M; Hsu V; Wu JY; Fiorentino D; Chung L
    Semin Arthritis Rheum; 2016 Dec; 46(3):344-349. PubMed ID: 27371996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-SSA/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study.
    Sánchez-Montalvá A; Fernández-Luque A; Simeón CP; Fonollosa-Plà V; Marín A; Guillén A; Vilardell M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-177-82. PubMed ID: 25372801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
    Sato LT; Kayser C; Andrade LE
    Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality and prognostic factors in Spanish patients with systemic sclerosis.
    Simeón CP; Armadans L; Fonollosa V; Solans R; Selva A; Villar M; Lima J; Vaqué J; Vilardell M
    Rheumatology (Oxford); 2003 Jan; 42(1):71-5. PubMed ID: 12509616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
    Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
    Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancies associated with systemic sclerosis.
    Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
    Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.